This article references the same study posted here. It's not redundant because it places greater emphasis on the fact that Argentina will be manufacturing the ivermectin. (Not sure how important that is.)
It is a product manufactured entirely in laboratories in the province, at a very low cost, and "without the interests of private laboratories behind the project." Ivermectin, a drug in an experimental stage for the treatment of Covid 19, was presented by Governor Gustavo Valdés together with doctors from the Institute of Cardiology ”
The drug Ivermectin, developed jointly by the Ministry of Public Health through the Crisis Committee of the Province and the Institute of Cardiology "Juana Francisca Cabral", if it is effective, it will prevent the disease from progressing and that the patient with Covid18 must be hospitalized for recovery. Hence, it will be used only with the non-hospitalized COVID-19 patient population
The director of the Ricardo Vallejos Institute of Cardiology stressed that it is a product manufactured entirely in laboratories in the province, at a very low cost, about two pesos per tablet. "We do not have any private pharmacological industry behind this study and neither do the researchers we participate receive additional income for this work," he remarked. "We are only guided by scientific interest.
The Ethics Committee of the Faculty of Medicine has already registered for the trials in coronavirus substances
" A great goal from the middle of the court, "Dr. Vallejos said about the development of the drug and pondered that the The Ministry of Public Health has centralized all actions against Covid 19, because it has allowed the protocol to be the same for everyone
A result will be obtained that can determine the efficacy of Ivermectin "We are presenting a scientific study endorsed by medical sciences, by the Faculty of Medicine of the Northeast National University (UNNE) in conjunction with an Institute that is one of the most prestigious that we have in Argentina and why not also in South America ", expressed the governor in the presentation
It was clarified that the drug does not entail "any health hazard" for people who enter the experimental program always voluntarily. "This research again puts the people of Corrientes at the forefront of studies in reference to the fight against COVID and it is something that has to fill us with pride ”, the president also said.
The director of the Ricardo Cardiology Institute explained that "in this pandemic, for the first time we will try to scientifically investigate this promising drug produced in Corrientes."
"Then the study will be analyzed to determine whether or not Ivermectin is effective from a clinical point of view against COVID-19," he added. In this regard, Vallejos expressed his satisfaction with the team of researchers that was formed for this objective and urged the voluntary participation of citizens, since "they will be contributing to science" in this period of pandemic.
Along the same lines, the general director of Epidemiology of the Province, Angelina Bobadilla, said that "carrying out this clinical study fills us with pride, because it will provide scientific evidence for the whole world." Ivermectin, as explained by the official, is a drug that is usually used to treat parasitic diseases, but it was detected that it produces an effect on the COVID virus. So the idea of the study is to treat patients with this drug to see if it reduces the viral load and, therefore, leads to a faster recovery.
"The study is single-center, that is, we organize it only with the Ministry of Health and the Crisis Committee, plus teams from the Cardiology Department and the Faculty of Medicine," said the official, adding that the main objective is to avoid hospitalization of the patient and, if this cannot be done, avoid mechanical assistance and other complications.
"Crises generate opportunities"
"Today is a day of joy for public health and it has to do with the importance of this study that will contribute to global knowledge regarding this new pathology that afflicts us and Corrientes' contribution to that scenario It is fundamental and fills us with pride ”, said the Minister of Public Health Ricardo Cardozo, close to the research project "When it was proposed to deploy this joint work," we did not doubt it and after having the endorsement of Governor Valdés, we formed a great team for this purpose ", and pondered that the study had been thoroughly evaluated by the Bioethics Committee of the Faculty of Medicine, "which guarantees transparency and seriousness." Cardozo remarked as a milestone that it is the first time that the Ministry of Public Health of the Province participates in a scientific investigation of these characteristics, underpinning one of the axes of the Governor's management, which is to promote knowledge and scientific research.
For the Minister, "crises generate opportunities, this is one of them and we could not miss it" and he closed by discounting the success of the mission, highlighting the vital support of the Institute of Cardiology with all the scientific experience that said institution has, " signal and pride of the Corrientes ”
[-] TrumpLyftAlles | 1 points | Aug 22 2020 08:39:47
This article references the same study posted here. It's not redundant because it places greater emphasis on the fact that Argentina will be manufacturing the ivermectin. (Not sure how important that is.)
It is a product manufactured entirely in laboratories in the province, at a very low cost, and "without the interests of private laboratories behind the project." Ivermectin, a drug in an experimental stage for the treatment of Covid 19, was presented by Governor Gustavo Valdés together with doctors from the Institute of Cardiology ”
The drug Ivermectin, developed jointly by the Ministry of Public Health through the Crisis Committee of the Province and the Institute of Cardiology "Juana Francisca Cabral", if it is effective, it will prevent the disease from progressing and that the patient with Covid18 must be hospitalized for recovery. Hence, it will be used only with the non-hospitalized COVID-19 patient population
The director of the Ricardo Vallejos Institute of Cardiology stressed that it is a product manufactured entirely in laboratories in the province, at a very low cost, about two pesos per tablet. "We do not have any private pharmacological industry behind this study and neither do the researchers we participate receive additional income for this work," he remarked. "We are only guided by scientific interest.
The Ethics Committee of the Faculty of Medicine has already registered for the trials in coronavirus substances
" A great goal from the middle of the court, "Dr. Vallejos said about the development of the drug and pondered that the The Ministry of Public Health has centralized all actions against Covid 19, because it has allowed the protocol to be the same for everyone
A result will be obtained that can determine the efficacy of Ivermectin "We are presenting a scientific study endorsed by medical sciences, by the Faculty of Medicine of the Northeast National University (UNNE) in conjunction with an Institute that is one of the most prestigious that we have in Argentina and why not also in South America ", expressed the governor in the presentation
It was clarified that the drug does not entail "any health hazard" for people who enter the experimental program always voluntarily. "This research again puts the people of Corrientes at the forefront of studies in reference to the fight against COVID and it is something that has to fill us with pride ”, the president also said.
The director of the Ricardo Cardiology Institute explained that "in this pandemic, for the first time we will try to scientifically investigate this promising drug produced in Corrientes."
"Then the study will be analyzed to determine whether or not Ivermectin is effective from a clinical point of view against COVID-19," he added. In this regard, Vallejos expressed his satisfaction with the team of researchers that was formed for this objective and urged the voluntary participation of citizens, since "they will be contributing to science" in this period of pandemic.
Along the same lines, the general director of Epidemiology of the Province, Angelina Bobadilla, said that "carrying out this clinical study fills us with pride, because it will provide scientific evidence for the whole world." Ivermectin, as explained by the official, is a drug that is usually used to treat parasitic diseases, but it was detected that it produces an effect on the COVID virus. So the idea of the study is to treat patients with this drug to see if it reduces the viral load and, therefore, leads to a faster recovery.
"The study is single-center, that is, we organize it only with the Ministry of Health and the Crisis Committee, plus teams from the Cardiology Department and the Faculty of Medicine," said the official, adding that the main objective is to avoid hospitalization of the patient and, if this cannot be done, avoid mechanical assistance and other complications.
"Crises generate opportunities"
"Today is a day of joy for public health and it has to do with the importance of this study that will contribute to global knowledge regarding this new pathology that afflicts us and Corrientes' contribution to that scenario It is fundamental and fills us with pride ”, said the Minister of Public Health Ricardo Cardozo, close to the research project "When it was proposed to deploy this joint work," we did not doubt it and after having the endorsement of Governor Valdés, we formed a great team for this purpose ", and pondered that the study had been thoroughly evaluated by the Bioethics Committee of the Faculty of Medicine, "which guarantees transparency and seriousness." Cardozo remarked as a milestone that it is the first time that the Ministry of Public Health of the Province participates in a scientific investigation of these characteristics, underpinning one of the axes of the Governor's management, which is to promote knowledge and scientific research.
For the Minister, "crises generate opportunities, this is one of them and we could not miss it" and he closed by discounting the success of the mission, highlighting the vital support of the Institute of Cardiology with all the scientific experience that said institution has, " signal and pride of the Corrientes ”
TLATODO: Annotate?
permalink